rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kimberlee C. Drapkin

Director

Company insider

Files Form 4 as: Director, LENZ Therapeutics; Director, Climb Bio; Director, Acumen Pharmaceuticals; Director, Kineta, Inc./de; President, CFO and Treasurer, Jounce Therapeutics; Chief Financial Officer, EPIX Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
100
Buys
0
Sells
18
Bought
$0
Sold
$827K
Companies
6
Companies where not an officer
4
First trade
16 Aug 2006
Last trade
15 Jun 2026
Last filed
15 Jun 2026

Companies traded

Where they are an officer
Jounce TherapeuticsOfficer · last 3 May 20230 buys · 18 sells
EPIX PharmaceuticalsOfficer · last 30 Jun 20090 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
LENZ LENZ TherapeuticsDirector · Biotechnology · last 15 Jun 20260 buys · 0 sells
CLYM Climb BioDirector · Biotechnology · last 5 Jun 20260 buys · 0 sells
ABOS Acumen PharmaceuticalsDirector · Biotechnology · last 3 Jun 20260 buys · 0 sells
Kineta, Inc./deDirector · last 30 Jun 20250 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jun 2026filed 15 Jun 2026LENZ LENZ Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,100 at $0.00filing
15 Jun 2026filed 15 Jun 2026LENZ LENZ Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,100 at $0.00filing
5 Jun 2026filed 8 Jun 2026CLYM Climb Biooption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
5 Jun 2026filed 8 Jun 2026CLYM Climb Biooption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
3 Jun 2026filed 5 Jun 2026ABOS Acumen PharmaceuticalsBiotechnologySEC FORM 4 Code A—35,500 at $0.00filing
3 Jun 2026filed 5 Jun 2026ABOS Acumen Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—53,250 at $0.00filing
3 Jun 2026filed 5 Jun 2026ABOS Acumen Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—53,250 at $0.00filing
3 Jun 2026filed 5 Jun 2026ABOS Acumen PharmaceuticalsBiotechnologySEC FORM 4 Code A—35,500 at $0.00filing
30 Jun 2025filed 2 Jul 2025Kineta, Inc./deoption or derivativeSEC FORM 4 Code D—20,000 at $0.00filing
30 Jun 2025filed 2 Jul 2025Kineta, Inc./deSEC FORM 4 Code D—13,794filing
25 Jun 2025filed 25 Jun 2025Kineta, Inc./deSEC FORM 4 Code A—6,000 at $0.00filing
23 Jun 2025filed 25 Jun 2025Kineta, Inc./deoption or derivativeSEC FORM 4 Code M—12,500 at $0.00filing
23 Jun 2025filed 25 Jun 2025Kineta, Inc./deSEC FORM 4 Code M$7,62512,500 at $0.61filing
23 Jun 2025filed 25 Jun 2025Kineta, Inc./deSEC FORM 4 Code F$1,2244,706 at $0.26filing
11 Jun 2025filed 11 Jun 2025LENZ LENZ Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—13,500 at $0.00filing
4 Jun 2025filed 5 Jun 2025CLYM Climb Biooption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
4 Jun 2025filed 5 Jun 2025ABOS Acumen Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—19,500 at $0.00filing
4 Jun 2025filed 5 Jun 2025ABOS Acumen PharmaceuticalsBiotechnologySEC FORM 4 Code A—12,800 at $0.00filing
28 Mar 2025filed 1 Apr 2025CLYM Climb Biooption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
4 Sep 2024filed 5 Sep 2024Kineta, Inc./deoption or derivativeSEC FORM 4 Code A—12,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed18

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.